Cardiology

BHF welcomes ultra-low emission zone introduction



BHF welcomes Ultra-Low Emission Zone introduction

The British Heart Foundation (BHF) has today welcomed the introduction of the Ultra-Low Emission Zone (ULEZ) in London.

From now on, vehicles that do not comply with the ULEZ due to their emissions standards will be charged £12.50 a day to enter the zone, while larger vehicles including lorries, buses and coaches, will be charged £100.

Around six out of ten global deaths related to outdoor pollution are caused by a heart attack or stroke.

In the UK, air pollution contributes to up to 36,000 deaths each year, and a significant proportion of these deaths occur in London, where pollution levels are often at their highest.

Speaking about the ULEZ, our Chief Executive, Simon Gillespie, said:

“The ULEZ will help reduce the levels of dangerous pollutants in the air Londoners breathe and crucially, it will help to protect the health of the most vulnerable people across the capital.

“Air pollution is a major threat to the UK’s health, and contributes to thousands of heart attacks and strokes every year. BHF-funded research has shown that tiny particles emitted from diesel vehicles can enter our bloodstream and silently damage our heart and circulatory systems.

“We now need to see other cities across the UK following suit, and more ambitious plans put in place nationally and locally to ensure that everyone gets the right to breathe air that won’t harm them. We need to see this action as soon as possible, beginning with the adoption of World Health Organization air pollution limits into UK law.”

If you liked this, why not try:


BHF welcomes ultra-low emission zone introduction was originally published in British Heart Foundation on Medium, where people are continuing the conversation by highlighting and responding to this story.

Source link




Related posts

Management of the adult Fontan patient

Newsemia

Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER Trial.

Newsemia

HF Mortality Trends Under Medicare Readmissions Reduction Program at Penalized and Nonpenalized Hospitals

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy